Savior Lifetec (ROCO:4167) Research & Development: NT$67 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4167 Savior Lifetec Corp ROCO:4167
68 GF Score
Price NT$20.60
GF Value NT$20.31
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Savior Lifetec Research & Development?

Savior Lifetec ROCO:4167 -0.24% 68 Research & Development is NT$67 Mil as of Dec. 2025. GuruFocus rates ROCO:4167 with a GF Score™ of 68/100 and a GF Value™ of NT$20.31 (Fairly Valued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Savior Lifetec's Research & Development for the three months ended in Dec. 2025 was NT$16 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was NT$67 Mil.

Savior Lifetec  (ROCO:4167) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Savior Lifetec Research & Development Related Terms

Savior Lifetec Research & Development Historical Data

* Premium members only.

The historical data trend for Savior Lifetec's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Savior Lifetec Research & Development Chart

Savior Lifetec Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 167.27 119.12 110.96 75.11 67.18

Savior Lifetec Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.72 16.67 16.61 17.71 16.19
ROCO:4167
68GF Score
Savior Lifetec Corp ROCO:4167
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Savior Lifetec Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$67 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NT$67 Mil mean?
Savior Lifetec (ROCO:4167) has a Research & Development of NT$67 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Savior Lifetec and its competitors.
Is Savior Lifetec's Research & Development too high?
Savior Lifetec's current Research & Development is NT$67 Mil. Overall, Savior Lifetec has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Savior Lifetec's Research & Development compare to VRTX and REGN?
Savior Lifetec's Research & Development of NT$67 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Savior Lifetec and its competitors. Savior Lifetec's current Research & Development is NT$67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Savior Lifetec stock overvalued right now?
Based on GuruFocus' analysis, Savior Lifetec (ROCO:4167) is currently considered Fairly Valued. The stock's GF Value™ is NT$20.31, compared to a current price of NT$20.60 — trading 1.4% above its estimated fair value. The current Research & Development is NT$67 Mil. Savior Lifetec's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Savior Lifetec (ROCO:4167), the current Research & Development is NT$67 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Savior Lifetec (ROCO:4167) Overvalued in 2026?

Based on GuruFocus' analysis, Savior Lifetec stock appears to be overvalued. The current stock price of NT$20.60 is trading 1.4% above its estimated GF Value™ of NT$20.31. GuruFocus considers Savior Lifetec to be Fairly Valued.

Key valuation signals for ROCO:4167:

  • Research & Development: NT$67 Mil
  • GF Value™: NT$20.31 vs. price of NT$20.60 (1.4% above fair value)
  • GF Score™: 68/100 with 4 warning signs

No single metric tells the full story. See the ROCO:4167 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Savior Lifetec Business Description

Address No. 1, Nanke 6th Road, Southern Taiwan Science Park, Sinshih District, Tainan, TWN, 744094
Savior Lifetec Corp is engaged in the research, development, design, manufacture, and sale of carbapenem generics, injection generics, controlled-release generics, development of new dosage forms and drugs, and the APIs, excipients, intermediates, and dosage forms of the aforementioned products. The company also provides medicine manufacturer technology and services. The company geographically operates in four regions: the Americas, Asia, Taiwan, and Europe.
68GF Score

Get the complete analysis for ROCO:4167

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$20.60
Price
NT$20.31
GF Value